Listed

Collegium Pharmaceutical, Inc: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Mar 18, 2016 and accepted by EDGAR at Mar 18, 2016, 17:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2015-10-01 to 2015-12-31$1.5mus-gaap:ResearchAndDevelopmentExpense
Research and development12 months2015-01-01 to 2015-12-31$8.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-10-01 to 2015-12-31−$9.4mus-gaap:OperatingIncomeLoss
Operating income12 months2015-01-01 to 2015-12-31−$26.9mus-gaap:OperatingIncomeLoss
Net income3 months2015-10-01 to 2015-12-31−$9.5mus-gaap:NetIncomeLoss
Net income12 months2015-01-01 to 2015-12-31−$27.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-10-01 to 2015-12-31−$0.46us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2015-01-01 to 2015-12-31−$1.48us-gaap:EarningsPerShareBasicAndDiluted
Basic EPS3 months2015-10-01 to 2015-12-31−$0.46us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-10-01 to 2015-12-3120,558,205 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure12 months2015-01-01 to 2015-12-31$362.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-12-31$95.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-12-31$96.9mus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$97.7mus-gaap:Assets
Current liabilitiesAt period end2015-12-31$8.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-12-31$12.6mus-gaap:Liabilities
Current portion of debtAt period end2015-12-31$2.7mus-gaap:DebtCurrent
Shareholders' equityAt period end2015-12-31$85.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-16-004252. Last ingested by Listed: Nov 10, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.